Identification of a pathogenic mutation in ATP2A1 via in silico analysis of exome data for cryptic aberrant splice sites.
Christine C BruelsChengcheng LiTonatiuh MendozaJamillah KhanHemakumar M ReddyElicia A EstrellaPartha S GhoshBasil T DarrasHart G W LidovChristina A PacakLouis M KunkelFrancois P ModaveIsabelle DraperPeter B KangPublished in: Molecular genetics & genomic medicine (2019)
This study confirms the potential of novel in silico algorithms to detect cryptic mutations in existing NGS data; expands the phenotypic spectrum of ATP2A1 mutations beyond classic Brody myopathy; and suggests that genetic testing of ATP2A1 should be considered in patients with clinical myotonia.